• West Nile Virus (WNV) Molecular Detection, Real-time PCR
  • 11-Deoxycortisol, Serum
  • Mycophenolic Acid, Serum
  • Calcium Sensing Receptor (CASR) Gene Mutation Analysis
  • Hypochondroplasia (FGFR3) Gene Mutation Analysis
  • Leishmania (Visceral Leishmaniasis) Antibody, IgG
  • Dehydroepiandrosterone Sulfate (DHEA-S)
  • BCR-ABL Translocation by RT-PCR, Quantitative, Blood
  • Protein, Total, 24 Hour, Urine
  • Cytochrome P450 3A4 (CYP3A4) Genotyping
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Methodology
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.
Loading...